Joussen A M, Murata T, Tsujikawa A, Kirchhof B, Bursell S E, Adamis A P
Laboratory for Surgical Research, Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Am J Pathol. 2001 Jan;158(1):147-52. doi: 10.1016/S0002-9440(10)63952-1.
Endothelial cell death is a hallmark of diabetic retinopathy. Its occurrence is required for the formation of acellular (devitalized) capillaries, lesions that produce irreversible retinal ischemia through their inability to support blood flow. The mechanisms underlying diabetic retinal endothelial cell injury and death remain largely unknown. The current study demonstrates that adherent leukocytes are temporally and spatially associated with retinal endothelial cell injury and death within 1 week of streptozotocin-induced experimental diabetes in rats. Moreover, the antibody-based neutralization of intercellular adhesion molecule-1 and CD18 is shown to prevent both leukocyte adhesion and retinal endothelial cell injury and death. These data highlight the central and causal role of adherent leukocytes in the pathogenesis of diabetic retinopathy. They also underscore the potential utility of anti-intercellular adhesion molecule1- and anti-CD18-based therapies in the treatment of diabetic retinopathy, a newly recognized inflammatory disease.
内皮细胞死亡是糖尿病视网膜病变的一个标志。无细胞(失活)毛细血管的形成需要内皮细胞死亡,这些病变由于无法支持血流而导致不可逆的视网膜缺血。糖尿病性视网膜内皮细胞损伤和死亡的潜在机制在很大程度上仍然未知。当前的研究表明,在链脲佐菌素诱导的大鼠实验性糖尿病1周内,黏附的白细胞在时间和空间上与视网膜内皮细胞损伤和死亡相关。此外,基于抗体的细胞间黏附分子-1和CD18中和作用可防止白细胞黏附以及视网膜内皮细胞损伤和死亡。这些数据突出了黏附白细胞在糖尿病视网膜病变发病机制中的核心和因果作用。它们还强调了基于抗细胞间黏附分子-1和抗CD18疗法在治疗糖尿病视网膜病变(一种新认识的炎症性疾病)中的潜在效用。